Is Integral Diagnostics Limited (ASX: IDX) A Healthcare Stock Worth Watching?
Short-term revenue falls haven’t held back IDX’s acquisition multiple arbitrage growth model, or its share price.
Integral Diagnostics (ASX: IDX)
Integral Diagnostics Limited (ASX: IDX) is an Australian healthcare services provider specialising in diagnostic imaging. Founded in 2008 and headquartered in Melbourne, the company operates a network of over 90 radiology clinics across Australia and New Zealand.
Integral Diagnostics’ services include MRI, CT, PET, ultrasound, and X-ray imaging, catering to general practitioners, medical specialists, and allied health professionals.
Integral Diagnostics listed on the ASX in October 2015 at an IPO price of $1.91 per share. The company continues to expand its presence in the diagnostic imaging sector.
10 Stocks I Bought For A Potential Discounted Capital Raise
Bail outs for debt holders are a relief for equity holders but that won’t necessarily mean the debt gets paid. For that, companies will need to raise capital…